№ files_lp_4_process_2_86339
File format: docx
Character count: 11506
File size: 26 KB
Academic source describing the manifestations, underlying mechanisms, and therapeutic approaches for Spleen QI deficiency according to Traditional Chinese Medicine, integrating historical background and modern interpretations.
Year:
2021
Region:
International
Topic:
Traditional Chinese Medicine, Spleen QI Deficiency
Document Type:
Academic Paper
Institution:
National Center for Complementary and Integrative Health
Author:
Student (name not specified)
Target Audience:
Students and researchers in complementary and integrative medicine
Period Covered:
Historical overview and current therapeutic approaches
Therapies Discussed:
Dietary therapy, Chinese herbs, Pharmaceutical treatment, Pulmonary and circulatory health management, Mental therapy
Symptoms Detailed:
Fatigue, bloating, acid reflux, diarrhea, nausea, dehydration, weak pulse, cold limbs
References:
Medicalnewstoday (2021), NCCIH (2021), Shushe & Zishen (2017), Zhou et al. (2019)
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
2023
Region / city:
Global
Topic:
Aquatic animal health
Document type:
Assessment report
Organization / institution:
World Organisation for Animal Health (WOAH)
Author:
Aquatic Animal Health Standards Commission
Target audience:
Veterinary and aquatic health professionals, policy makers
Period of validity:
Not specified
Approval date:
Not specified
Date of amendments:
Not specified
Year:
2026
Region:
Multicenter
Subject:
Medical imaging, radiomics
Document type:
Supplementary table
Institution:
Imaging Biomarker Standardization Initiative (IBSI)
Software used:
ITK-SNAP 4.0.1, nnU-Net v2, Python 3.9, Pyradiomics 3.1.0
Imaging modality:
Computed tomography (CT)
Patient preparation:
Fasting state
Contrast agent:
Iodinated
Segmentation method:
Manual modification and automatic segmentation
Radiomics features:
First Order Statistics, shape features, GLCM, GLDM, GLRLM, GLSZM, NGTDM
Data format:
DICOM converted to NIfTI
ROI delineation:
Liver and spleen
Experts involved:
2 radiologists with cross-validation by 1 senior radiologist
Acquisition phases:
Arterial, venous, delayed
Year:
2017
Region / City:
Livermore, CA
Subject:
Sprinkler Deficiency Repairs
Document Type:
Task Order Proposal Request
Issuing Agency:
Department of Veterans Affairs Network Contracting Office 21
Author:
Department of Veterans Affairs
Target Audience:
Contractors with MATOC contracts from VISN 21
Period of Validity:
Not specified
Approval Date:
June 29, 2017
Date of Changes:
Not specified
Description:
Invitation to contractors with awarded MATOC contracts for VA Palo Alto Health Care System sprinkler deficiency repairs proposal submission, with details on site visit and proposal conference.
Year:
2023
Region / city:
USA
Topic:
Iron Deficiency Anemia Treatment
Document type:
Medical guideline
Organization / institution:
Centers for Disease Control and Prevention (CDC)
Author:
Not specified
Target audience:
Pregnant individuals, healthcare professionals
Period of validity:
Ongoing
Date of approval:
2023
Date of revisions:
15 February 2021, 31 March 2022, April 2023
Context:
This document provides clinical guidelines for the treatment of iron deficiency anemia during pregnancy, including oral and IV iron therapy options.
Year:
2023
Region / city:
ESS (European Spallation Source)
Topic:
Occupational Health & Safety, Hazard Management
Document type:
Guideline
Organization / Institution:
European Spallation Source (ESS)
Author:
B. Winér
Target audience:
ESS staff, safety engineers, occupational health and safety professionals
Validity period:
Not specified
Approval date:
Not specified
Date of revisions:
Not specified
Year:
Not specified
Region / City:
Not specified
Topic:
Distribution system deficiencies, load forecasting, distribution planning
Document type:
Report
Organization / Institution:
Not specified
Author:
Not specified
Target audience:
Distribution system operators, energy planners
Period of validity:
Not specified
Approval date:
Not specified
Modification date:
Not specified
Year:
2016
Region / city:
York, UK
Topic:
Gene therapy for ADA-SCID
Document type:
Review article
Organization / institution:
National Institute for Health and Care Excellence (NICE)
Author:
Emily South, Edward Cox, Nick Meader, Nerys Woolacott, Susan Griffin
Target audience:
Healthcare professionals, decision-makers in health technology assessment
Period of validity:
2016
Approval date:
May 2016
Date of changes:
Not specified
Date:
19 March 2024
Organisation:
Niemann-Pick UK (NPUK)
Address:
Suite 2, Vermont House, Concord, Washington NE37 2SQ
Addressee:
Dr Mark Chakravarty, Lead Non-executive Director for Appeals
Institution:
National Institute for Health and Care Excellence
Subject:
Appeal of Final Draft Guidance decision
Technology Appraised:
Olipudase alfa
Indication:
Acid sphingomyelinase deficiency (Niemann-Pick disease) type AB and type B
Reference ID:
ID3913
Grounds for Appeal:
Failure to act fairly; Unreasonable recommendation in light of evidence
Document Type:
Formal appeal letter
Geographical Scope:
United Kingdom
Cited Studies:
Raebel et al., Orphanet Journal of Rare Diseases (2024); Fraser et al.
Year:
Not specified
Region / City:
Not specified
Theme:
Magnesium deficiency, Type-2 diabetes
Document Type:
Research Paper
Organization / Institution:
Not specified
Author:
Not specified
Target Audience:
Not specified
Period of Action:
Not specified
Approval Date:
Not specified
Date of Changes:
Not specified
Subject:
Forward Showing Deficiencies and Deficiency Charge Calculation
Forward Showing Years:
FS Year 1; FS Year 2
Seasons Covered:
Summer; Winter
Months Covered:
Jun; Jul; Aug; Sep; Nov; Dec; Jan; Feb; Mar
Estimated CONE Value:
91.81 $-kW Year
Total Program P50 Load - Summer (FS Year 1):
75,689
Total Program P50 Load - Winter (FS Year 1):
61,481
Total Program P50 Load - Summer (FS Year 2):
78,100
Total Program P50 Load - Winter (FS Year 2):
67,500
Maximum Monthly Summer Deficiency (FS Year 1):
22
Maximum Monthly Winter Deficiency (FS Year 1):
28
Maximum Monthly Summer Deficiency (FS Year 2):
30
Maximum Monthly Winter Deficiency (FS Year 2):
30
Total Deficiency Charge (FS Year 1):
$4,957,740.00
Total Deficiency Charge (FS Year 2):
$6,625,621.67
Currency:
USD
Type of Document:
Technical calculation example with tabulated data
Calculation Basis:
Seasonal deficits; Annual CONE factor; Monthly incremental charges
Authors:
Jianhua Rao; Jiannan Qiu; Ming Ni; Hao Wang; Peng Wang; Lei Zhang; Zeng Wang; Mu Liu; Feng Cheng; Xuehao Wang; Ling Lu
Affiliations:
Hepatobiliary Center of The Affiliated Cancer Hospital (Jiangsu Cancer Hospital) and The First Affiliated Hospital, Nanjing Medical University; Research Unit of Liver Transplantation and Transplant Immunology, Chinese Academy of Medical Sciences; Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment; Collaborative Innovation Center for Personalized Cancer Medicine; State Key Laboratory of Reproductive Medicine
Institution:
Nanjing Medical University
Country:
China
Type of Document:
Supplementary Material
Discipline:
Immunology; Hepatology; Molecular Biology
Subject:
Role of macrophage Nrf2 deficiency and Timp3-mediated RhoA/ROCK pathway in ischemic liver injury
Experimental Models:
Mouse models; Bone marrow–derived macrophages (BMMs); Hepatic macrophages
Methods:
Cell isolation and culture; Biochemical measurements; Histopathology; Immunohistochemistry; Immunofluorescence; TUNEL staining; MDA, GSH and MPO assays; Western blotting; qRT-PCR; ELISA; RNA sequencing; Chromatin immunoprecipitation
Correspondence:
Ling Lu; Xuehao Wang; Feng Cheng
Equal Contribution:
Jianhua Rao; Jiannan Qiu; Ming Ni
Year:
2024
Region / City:
Australia
Topic:
Colour Vision Deficiency Testing
Document Type:
Consultation Paper
Issuing Organization:
Civil Aviation Safety Authority (CASA)
Author:
CASA
Target Audience:
Pilots, Flight Examiners, Aviation Medical Practitioners
Effective Period:
Ongoing until April 2024
Approval Date:
2024
Modification Date:
None specified
Institution:
Centrum Medische Genetica UZ Gent
Document type:
Clinical checklist
Subject:
Primary immune deficiency (PID) gene panel analysis
Legal reference:
Artikel 33, K.B. 10.11.2012 (in werking 1.1.2013)
Regulatory authority:
Recognized clinical geneticist validation requirement
Target group:
Referring physicians and clinical geneticists
Required information:
Patient identification, PID classification, clinical manifestations, screening results, familial history
Classification system:
International Union of Immunological Societies (IUIS) Expert Committee
Purpose:
Submission of clinical data for PID panel request validation
Fields included:
Patient name, date of birth, referring physician, RIZIV number, clinical indications, laboratory and genetic screening results
Country:
United Kingdom
Topic:
Hereditary angioedema and acquired C1 inhibitor deficiency
Document type:
Medical research article
Study type:
National survey
Authors:
Patrick FK Yong; Tanya Coulter; Tariq El-Shanwany; Tomaz Garcez; Scott Hackett; Rashmi Jain; Sorena Kiani-Alikhan; Ania Manson; Sadia Noorani; Catherine Stroud; Christine Symons; Ravishankar Sargur; Cathal Steele; Hana Alachkar; Ariharan Anantharachagan; Peter D Arkwright; Jolanta Bernatoniene; Malini Bhole; Lindsay Brown; Matthew Buckland; Siobhan Burns; Charu Chopra; James Darroch; Elizabeth Drewe; Jillian Edmonds; Anjali Ekbote; Shuayb Elkhalifa; Sarah Goddard; Dorothea Grosse-Kreul; Padmalal Gurugama; Rosie Hague; Richard Herriot; Archana Herwadkar; Stephen M Hughes; Laura Jones; Sara Lear; Elizabeth McDermott; Sai Hurng Kham Murng; Arthur Price; Vyanka Redenbaugh; Alex Richter; Andrew Riordan; Fiona Shackley; Julia Stichbury; Debbie Springett; Michael D Tarzi; Moira Thomas; Pavaladurai Vijayadurai; Austen Worth
Institutions:
Multiple NHS trusts and university hospitals across England, Scotland, Wales, and Northern Ireland
Corresponding author:
Patrick FK Yong
Corresponding institution:
Frimley Health NHS Foundation Trust
Methodology:
Questionnaire survey of specialist centres managing hereditary angioedema and acquired C1 inhibitor deficiency
Number of participating centres:
37
Patient population:
Individuals with HAE-1/2, HAE with normal C1 inhibitor, and acquired C1 inhibitor deficiency
Sample size:
1265 patients
Medical conditions studied:
Hereditary angioedema; acquired C1 inhibitor deficiency
Key treatments mentioned:
Danazol; C1 inhibitor replacement therapy; icatibant; tranexamic acid
Funding source:
Unrestricted grant from Pharming
Keywords:
hereditary angioedema; acquired C1 inhibitor deficiency; epidemiology; demographics; treatment modalities; United Kingdom
Year:
2026
Region / City:
Laboratory mouse model
Topic:
Iron metabolism and erythropoiesis
Document type:
Supplemental data / research article
Institution:
Research laboratory
Authors:
Not specified
Target audience:
Biomedical researchers
Experimental period:
Chronic dietary iron deficiency and acute erythropoietic stress experiments
Date of data collection:
Not specified
Techniques used:
qRT-PCR, Western blot, hematological analysis, flow cytometry
Animal model:
WT (IRE+/+) and Dmt1IREΔ/Δ mice
Treatments:
EPO injection, PHZ-induced hemolysis, Fe-deficient diet
Measured parameters:
Ferritin (FTH1, FTL1), FPN, HEPH expression, RBC, HBG, HCT, MCV, MCH, MCHC, RDW
Year:
2026
Region / City:
Not specified
Topic:
Pediatric endocrinology, growth hormone therapy
Document Type:
Clinical trial information letter
Organization / Institution:
Not specified
Author:
Not specified
Target Audience:
Parents and guardians of children with isolated growth hormone deficiency
Study Type:
Non-inferiority randomized controlled trial
Purpose:
To evaluate the final height outcomes in children with I-GHD after discontinuation vs continuation of GH therapy
Participation:
Voluntary
Method:
GH stimulation test
Year:
2026
Region / city:
United Kingdom
Topic:
Health and nutrition
Document type:
Educational questionnaire
Institution:
National Health Service (NHS)
Target audience:
Teenagers
Key terms:
Iron deficiency, anaemia, haem iron, non-haem iron, vitamins
Format:
Multiple-choice and true/false questions
Language:
English
Year:
2024
Region / City:
Sheffield
Theme:
Cognitive Behavioural Therapy, Mental Health, Postgraduate Education
Document Type:
Academic Information Guide
Organization:
University of Sheffield
Author:
University of Sheffield
Target Audience:
Healthcare professionals, postgraduate students
Period of Validity:
Ongoing
Approval Date:
Not specified
Date of Last Update:
Not specified
Year:
2021
Region / City:
Oxford
Topic:
Occupational Therapy, Physiotherapy, Children’s Development
Document Type:
Intervention Programme
Institution:
Oxford Health NHS Foundation Trust
Author:
Oxford Health Children’s Integrated Therapies
Target Audience:
Parents, Teachers, Children with motor difficulties
Period of validity:
12 weeks
Approval Date:
Not specified
Modification Date:
Not specified
Context:
A guide designed for parents and educators to support children with developmental motor difficulties over a 12-week period, with a focus on fine and gross motor skills, attention, and self-care tasks.
Year:
2023
Region / city:
Sheffield
Topic:
Psychological Wellbeing Practitioner training
Document type:
Handbook
Institution:
University of Sheffield
Author:
University of Sheffield
Target audience:
Trainees and clinical supervisors
Period of validity:
March 2023
Approval date:
March 2023
Date of changes:
N/A
Contextual description:
Handbook for postgraduate training in Low Intensity Psychological Interventions, outlining the course structure, requirements, and resources for trainees and clinical supervisors.